CLICK HERE to watch the recorded webinar
Blended Learning Journey on Thyroid Disorders 2024
Thyroid biomarker testing is the cornerstone of diagnosis, but is beset by issues of reproducibility between laboratories, within laboratories and even between samples from the same patient taken at different times of the day. Patients experience transient changes in thyroid parameters, and levels are impacted by age and ethnicity (Jonklaas, 2019), all of which need to be accounted for in deciding whether a patient has thyroid dysfunction. Early accurate diagnosis of thyroid problems is a real issue for patient quality of life and in preventing secondary health problems. Related to this subject is the need for awareness of the way that thyroid biomarkers, particularly thyroid stimulating hormone (TSH), change as a patient ages, to avoid over treatment of older adults. Ethnicity and weight are also key issues for assessment of TSH levels. Pregnancy and hypothyroidism remain an area of educational need, as does long-term monitoring for women who develop post-partum hypothyroidism following hypothyroidism pre- or during pregnancy. The unregulated and open nature of health information on the internet and social media can lead to patient misinformation. The ability to discuss contentious and misleading information with patients is a skill in increasing demand in the healthcare community.
At the end of the blended learning journey, participants will be able to:
Clinicians involved in endocrinology, particularly thyroid disorders and general practice; some content of interest to pediatricians, biochemists, clinical and research scientists, and those involved in pre-natal, pregnancy and post-natal care.
The official language of this educational programme will be English. Simultaneous translation into Spanish and Chinese will be provided.
The BLENDED LEARNING JOURNEY ON THYROID DISORDERS 2024 will be submitted for CME accreditation from the European Accreditation Council for Continuing Medical Education (EACCME), and/ or the European Board for Accreditation of Continuing Education for Health Professionals (EBAC) and for Continuing Professional Development (CPD) credits.
Martin Savage is Emeritus Professor of Paediatric Endocrinology at William Harvey Research Institute, Barts and the London School of Medicine & Dentistry, Queen Mary, University of London. He was head of the Paediatric Endocrine Unit at Barts and the London School of Medicine from 1982 to 2007. He has interests in growth disorders, specifically those with abnormalities in the GH-IGF-1 axis and in phenotype-genotype relationships of GH-IGF-1 axis defects, notably GH resistance. He published the first human case of an IGF-1 gene defect in the New England Journal of Medicine in 1996. His other interests are Cushing’s syndrome and growth in chronic inflammatory diseases. He was General Secretary of the European Society for Paediatric Endocrinology (ESPE) from 1997 to 2004. He has lectured in 60 countries and has published 482 original articles, reviews, textbook chapters and books. In 2007, he was awarded the ESPE Andrea Prader Prize for contributions to paediatric endocrinology and in 2018 he received a Visionary Award from the American Human Growth Foundation. In 2022, he received a Research Excellence Award from the Dr Sulaiman Al Habib Medical Journal in Riyadh, and the British Society of Paediatric Endocrinology & Diabetes James M. Tanner Lifetime Achievement Award. He continues to lecture nationally and internationally.
Trevor E Angell, MD is Associate Professor of Clinical Medicine in the Division of Endocrinology and Diabetes and the Associate Medical Director of the Thyroid Center at Keck School of Medicine of the University of Southern California, Los Angeles, California, USA. Dr. Angell’s clinical and research interests span all thyroid disease, with a focus on the diagnosis and management of nodules and cancer. His past research includes the immune phenotype of thyroid cancers, and substantial clinical research on the optimal management of thyroid nodules. His current research focuses on the immune cell interactions in autoimmune thyroid diseases, including Hashimoto’s thyroiditis and immune-checkpoint inhibitor induced thyroiditis. He is a current member of the American Thyroid Association’s thyroid nodule guidelines taskforce, and a past chair of the Patient Affairs & Education Committee. He is the current Editor-in-Chief of Clinical Thyroidology. He also is committed to medical education, serving as an associate program director for the USC and Los Angeles General internal medicine residency program. He is a member of the Endocrine Society’s In-Training Examination Steering Committee and is an organizer for local and national CME events.
Bernadette Biondi is Full Professor of Internal Medicine at the University of Naples Federico II Medical School, Italy, where she teaches cardiovascular endocrinology and researches clinical thyroidology, with a special focus on subclinical thyroid dysfunction. She has recently been member of the Awards Committee Roster of the American Thyroid Association and chaired the European Thyroid Association’s task force for the development of clinical practice guidelines for the diagnosis and treatment of subclinical hyperthyroidism in 2015. She is also member of the editorial board of important scientific journals such as Clinical Thyroidology and Frontiers in Thyroid Endocrinology. Professor Biondi is author and co-author of numerous papers published in journals including the American Journal of Medicine, Annals of Internal Medicine, Circulation, Endocrine Reviews, The European Heart Journal, The European Journal of Endocrinology, Endocrinology Metabolic Clinics of North America, Journals of the American College of Cardiology, The Journal of Clinical Endocrinology and Metabolism, JAMA, Lancet, The New England Journal of Medicine and Thyroid.
Gabriela Brenta is Chief of the Thyroid Division of the Endocrinology Department of the Dr Cesar Milstein Hospital in Buenos Aires, and Assistant Professor at the Medical School of the University of Buenos Aires in Argentina. Alongside her clinical commitments, Dr Brenta is an active and well-published researcher – her main areas of scientific interest include the cardiovascular and metabolic effects of thyroid hormones, as well as nodular thyroid disease including thyroid cancers. Her professional affiliations include pro-secretary of the Argentine Society of Endocrinology and Metabolism (SAEM), as well as membership of the thyroid section of SAEM. Dr Brenta served as President of the Latin American Thyroid Society 2017–2019 and is currently a member of the Pregnancy and Thyroid Task Force and the Women in Thyroid (WIT) group of the American Thyroid Association. Dr Brenta is a member of the editorial committee of Thyroid, The Journal of Endocrinology Investigation, Revista Argentina de Endocrinología y Metabolismo, and Clinical Thyroidology.
Kristien Boelaert is a Professor of Endocrinology at the University of Birmingham and a Consultant Endocrinologist at University Hospitals Birmingham. She is an active researcher in the field of thyroid diseases. She has published more than 200 papers (H-index 48) and has received more than £10 million in research grant funding. Kristien was the recipient of the inaugural Outstanding Clinical Practitioner Award from the Society for Endocrinology. She was the Clinical Lead for the NICE Guidelines on Thyroid Diseases and leads the National Consensus Statements on Management of Thyroid Cancer. She is a member of the RCOG Green-Top and the American Thyroid Association guideline panels on Thyroid Diseases in Pregnancy. Kristien is Senior Editor for the Journal of the Endocrine Society and Endocrine Connections. She serves on the Editorial Boards of several endocrine journals including Lancet Diabetes & Endocrinology, Thyroid and Clinical Endocrinology. She is President of the British Thyroid Association, Chair of the Clinical Committee of the Society for Endocrinology and member of the SfE Council, The ATA Programme Organising Committee, the ETA Executive Committee and the RCP Specialist Certificate Examination Board.
Tim Korevaar is an obstetric internist and endocrinologist at the Erasmus University Medical Center in Rotterdam, the Netherlands. His key research interest is gestational and placental endocrinology including thyroid disease in fertility and pregnancy. Doctor Korevaar is the co-founder and coordinator of the Consortium on Thyroid and Pregnancy, the co-chair of the current ATA guidelines on Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum and co-chair of the European Thyroid Association Guidelines on Hypothyroidism and Thyroid Autoimmunity During Pregnancy. He has been awarded with the Dutch Royal Academy of Sciences Early Career Award and the ESE Young Investigator Award and has published more than 130 peer-reviewed articles.
Salman Razvi is a Senior Lecturer in Endocrinology at Newcastle University and a Consultant Endocrinologist at Queen Elizabeth Hospital. His doctoral thesis was based on assessing cardiovascular risk in subclinical hypothyroidism. After this, he has continued to pursue research evaluating the action of thyroid hormones particularly on the cardiovascular system. The focus of his research has been on investigating the association of thyroid function with cardiovascular events in various populations. He is the chief investigator of several projects funded by various statutory funding bodies as well as charities. He has more than 110 peer-reviewed publications and book chapters mainly relating to thyroid dysfunction. His main research programmes include investigating the treatment of subclinical hypothyroidism with thyroid hormones in acute myocardial infarction and age-appropriate treatment of hypothyroidism in the elderly. Dr Razvi is also the Director of Research and Development at the Queen Elizabeth Hospital NHS Trust, Gateshead and the Metabolic and Endocrine Lead for the North East England Local Clinical Research Network. He is a member of the editorial board of JCEM, Thyroid, Frontiers in Endocrinology and Journal of Endocrinological Investigations. In addition, Dr Razvi is a member of the executive committee of the European Thyroid Association, Programme Organising Committee of the British Society for Endocrinology and the medical advisor to the patient-led charity the British Thyroid Foundation.
Stay in the know with our CME updates
